Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2024.
Financials
Financial year 2025
Pharma City 2 from Brussel, company number BE1003993550, closed financial year 2025 with a result of € 182,873 after tax. For that financial year Pharma City 2 recorded a gross margin of € 550,231 and equity of € 400,627. Compared with financial year 2024, the result moved from € 39,053 to € 182,873. Profitable, and profit is growing. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.
€ 400,627
▲ 84% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 182,873
▲ € 143,820 vs 2024
Profit after tax over the fiscal year.
€ 282,439
▲ 21% vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 221,927.
People and assets in 2025
€ 200,416
▲ 13% vs 2024
Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
€ 7,154
▼ 23% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 544,918
▼ 16% vs 2024
Loans from banks and other lenders, long and short.
€ 703,659
▲ 19% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 75,756
▲ 113% vs 2024
Taxes, VAT and social contributions still to pay.
| 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|
| Gross margin | € 329,015 | € 550,231 | ▲ 67% |
| Profit after taxes | € 39,053 | € 182,873 | ▲ € 143,820 |
| Equity | € 217,753 | € 400,627 | ▲ 84% |
| Total debts | € 1,332,881 | € 1,324,334 | ▼ 1% |
| Cash | € 233,141 | € 282,439 | ▲ 21% |
| Retained profit | € 39,053 | € 221,927 | ▲ € 182,873 |
| Bank debt | € 648,951 | € 544,918 | ▼ 16% |
| Balance sheet total | € 1,550,634 | € 1,724,960 | ▲ 11% |
Key figures of Pharma City 2, fiscal years 2024 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Pharma City 2?
What happened at Pharma City 2 in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 182,873 (▲ € 143,820 vs 2024). filed late Source: NBB ↗
- Incorporation, published in the Gazette. Source: Staatsblad ↗
- New establishment in Brussel. KBO
In short
From € 39,053 profit in 2024 to € 182,873 profit in 2025.
Paid € 79,938 in corporate taxes since 2024.
Best year ever: 2025, with € 182,873 profit.
Management
Behind Pharma City 2 is Metin Bakar. Metin Bakar is also behind PHARMABAK, WEST PHARMA, B&B PHARMA, "WESTLAND PHARMA" and BKR.
Directors
According to the 2025 annual accounts
Establishments
Establishment units
Physical locations of this company
Kruidtuinlaan 17a-18b
1000 Brussel
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Shareholders according to the Official Gazette deeds
Who contributed at incorporation and at capital increases, with the deed as source. Later share transfers are not published in the Gazette.
Incorporation
Source: Deed ↗- BAKAR Metin(comparant fondateur) 100%
Details
- Company number
- 1003.993.550
- VAT number
- BE 1003.993.550
- Registered office
- Kruidtuinlaan 17a-18b, 1000 Brussel
- Names & denominations
- Pharma City 2
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 28 December 2023
- Peppol
- Active · Active since 26 Nov 2025
- Activities · NACE
Detailhandel in farmaceutische producten